TherapeuticsMD, Inc. (NASDAQ:TXMD – Get Rating) – Analysts at Cantor Fitzgerald reduced their FY2023 earnings estimates for shares of TherapeuticsMD in a note issued to investors on Tuesday, May 16th. Cantor Fitzgerald analyst L. Chen now expects that the company will earn ($0.38) per share for the year, down from their previous estimate of $0.19. […]
BOCA RATON, Fla. — BOCA RATON, Fla. — TherapeuticsMD Inc. on Monday reported a loss of $3.6 million in its first quarter. On a per-share basis, the Boca Raton, Florida-based. | May 15, 2023
TherapeuticsMD (NASDAQ:TXMD – Get Rating) and Sanofi (NASDAQ:SNY – Get Rating) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, dividends, valuation, profitability, institutional ownership, risk and analyst recommendations. Risk & Volatility TherapeuticsMD has a beta of 1.18, indicating that its […]
/PRNewswire/ NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company on a quest to transform cardiometabolic diseases, today.
NeuroBo Pharmaceuticals (NRBO) Appoints Mark A Glickman to its Board streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.